Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Urinary VEGF and MMP Levels in Patients Receiving Radiation Therapy for Glioblastoma Multiforme: Prospective Determination of a Predictive Value for Recurrence

NCT00392548 is registered in ClinicalTrials.gov with Tel-Aviv Sourasky Medical Center as lead sponsor.

NCT NCT00392548
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00392548 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Urinary VEGF and MMP Levels in Patients Receiving Radiation Therapy for Glioblastoma Multiforme: Prospective Determination of a Predictive Value for Recurrence
Lead sponsor
Tel-Aviv Sourasky Medical Center
Phase
Observational
Overall status
Unknown status
Start date
October 31, 2006
Completion date
October 31, 2006
Enrollment
130
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma